Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PCSA Processa Pharmaceuticals, Inc.

未开盘 07-22 16:00:00 EDT

1.64

+0.01

+0.61%

盘后1.64

+0.000.00%

17:20 EDT

最高1.69	最低1.63	成交量2.41万
今开1.63	昨收1.63	日振幅3.69%
总市值468.71万	流通市值406.89万	总股本285.80万
成交额3.98万	换手率0.97%	流通股本248.11万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PCSA","market":"US","secType":"STK","nameCN":"Processa Pharmaceuticals, Inc.","latestPrice":1.64,"timestamp":1721678400000,"preClose":1.63,"halted":0,"volume":24099,"hourTrading":{"tag":"盘后","latestPrice":1.64,"preClose":1.64,"latestTime":"17:20 EDT","volume":50,"amount":85.5,"timestamp":1721683244601},"delay":0,"floatShares":2481063,"shares":2858007,"eps":-5.978381,"marketStatus":"未开盘","marketStatusCode":0,"change":0.01,"latestTime":"07-22 16:00:00 EDT","open":1.6299,"high":1.69,"low":1.6299,"amount":39763.398198,"amplitude":0.036871,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.978381,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721721600000},"adr":0,"adjPreClose":1.63,"preHourTrading":{"tag":"盘前","latestPrice":1.62,"preClose":1.63,"latestTime":"08:41 EDT","volume":111,"amount":179.9100099,"timestamp":1721652102585},"postHourTrading":{"tag":"盘后","latestPrice":1.64,"preClose":1.64,"latestTime":"17:20 EDT","volume":50,"amount":85.5,"timestamp":1721683244601},"volumeRatio":0.717241},"requestUrl":"/m/hq/s/PCSA","defaultTab":"news","newsList":[{"id":"2452167314","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.14%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452167314","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452167314?lang=zh_cn&edition=full","pubTime":"2024-07-18 00:27","pubTimestamp":1721233645,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日00时27分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.14%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.98%。其相关个股中，Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为3223.61%、1365.33%、291.95%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、4D Molecular Therapeutics, Inc.，振幅分别为76.39%、46.25%、45.71%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718002725941f7f74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718002725941f7f74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2450364610","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450364610","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450364610?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:57","pubTimestamp":1720709861,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时57分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.26%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc、Omniab Inc C/Wts 涨幅较大，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为590.27%、516.29%、366.23%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited，振幅分别为149.07%、88.60%、82.31%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112257429681c0c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112257429681c0c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2449670974","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘大幅下挫5.77%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449670974","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449670974?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:24","pubTimestamp":1720448666,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时24分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.77%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222427af91183b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222427af91183b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2449429361","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌6.08%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449429361","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449429361?lang=zh_cn&edition=full","pubTime":"2024-07-05 22:03","pubTimestamp":1720188230,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日22时03分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅跳水6.08%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Kintara Therapeutics, Inc.、Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2301.56%、1381.34%、46.51%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Mediwound Ltd.，振幅分别为149.83%、41.31%、33.49%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052203509681a2b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052203509681a2b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2448499481","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘急速跳水5.69%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448499481","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448499481?lang=zh_cn&edition=full","pubTime":"2024-07-03 22:53","pubTimestamp":1720018390,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日22时53分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.69%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703225311968193b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703225311968193b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2448949809","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大跌6.25%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448949809","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448949809?lang=zh_cn&edition=full","pubTime":"2024-07-02 02:22","pubTimestamp":1719858125,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日02时22分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速下挫6.25%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Senti Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Seastar Medical Holding Corporation涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为759.75%、200.16%、122.54%，振幅较大的相关个股有Senti Biosciences, Inc.、Cingulate Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为101.49%、82.81%、56.57%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702022205968187aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702022205968187aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2446681081","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446681081","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446681081?lang=zh_cn&edition=full","pubTime":"2024-06-28 23:06","pubTimestamp":1719587193,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日23时06分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.26%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628230634aef72c5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628230634aef72c5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2446582275","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446582275","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446582275?lang=zh_cn&edition=full","pubTime":"2024-06-26 01:41","pubTimestamp":1719337305,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日01时41分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.06%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为942.91%、234.44%、178.20%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.，振幅分别为272.73%、77.13%、47.00%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062601414696816add&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062601414696816add&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2445915497","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大涨6.48%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445915497","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445915497?lang=zh_cn&edition=full","pubTime":"2024-06-22 03:21","pubTimestamp":1718997687,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日03时21分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速拉升6.48%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622032127aef6103f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622032127aef6103f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2444115017","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大涨7.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444115017","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444115017?lang=zh_cn&edition=full","pubTime":"2024-06-18 03:22","pubTimestamp":1718652164,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日03时22分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速拉升7.43%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Biocardia Inc C/Wts 06/08/2024涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Longeveron Inc.较为活跃，换手率分别为5061.30%、3574.05%、194.06%，振幅较大的相关个股有Mustang Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Azitra Inc，振幅分别为524.62%、79.35%、59.41%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618032244af8de713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618032244af8de713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2443672939","title":"Processa Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443672939","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443672939?lang=zh_cn&edition=full","pubTime":"2024-06-14 23:43","pubTimestamp":1718379793,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日23时43分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.18%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。消息层面，截至23时43分，《H.C. Wainwright维持Processa Pharmaceuticals买入评级，维持目标价8美元》资讯为影响Processa Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614234314aef50c1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614234314aef50c1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2442552523","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅下挫6.67%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442552523","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442552523?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:40","pubTimestamp":1718199651,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时40分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速下挫6.67%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。消息层面，截至21时40分，《H.C. Wainwright维持Processa Pharmaceuticals买入评级，维持目标价8美元》资讯为影响Processa Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612214052941ee10e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612214052941ee10e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2442999623","title":"BUZZ-癌症治疗早期研究数据良好，Processa 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2442999623","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442999623?lang=zh_cn&edition=full","pubTime":"2024-06-11 21:22","pubTimestamp":1718112127,"startTime":"0","endTime":"0","summary":"    6月11日 - ** 药物开发商 Processa Pharmaceuticals    股价盘前上涨 12.7% 至 1.78 美元 ** 该公司宣布： ，最近完成的癌症联合疗法NGC-Cap早期研究的初步评估结果显示了积极的疗效。** 该疗法是 PCSA 候选癌症疗法 PCS6422 与已获批准的化疗药物卡培他滨的组合，在三期或四期胃癌患者中进行了测试 ** 公司称，在 12 名接受治疗的可评估患者中，有 8 人的无进展生存期约为 5 至 11 个月。** 公司表示，将在乳腺癌患者的中期研究中进一步评估研究中测试的两种剂量方案，以确定治疗的最佳剂量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCSA","BK4007","BUZZ"],"gpt_icon":0},{"id":"2442829498","title":"Processa Pharmaceuticals, Inc.盘中异动 快速跳水6.06%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442829498","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442829498?lang=zh_cn&edition=full","pubTime":"2024-06-11 00:40","pubTimestamp":1718037652,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日00时40分，Processa Pharmaceuticals, Inc.股票出现异动，股价急速下挫6.06%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611004053af8cc649&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611004053af8cc649&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2441093231","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441093231","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441093231?lang=zh_cn&edition=full","pubTime":"2024-06-08 00:16","pubTimestamp":1717777019,"startTime":"0","endTime":"0","summary":"北京时间2024年06月08日00时16分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅下跌6.21%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060800170096812f8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060800170096812f8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2441740504","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘大幅下挫5.03%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441740504","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441740504?lang=zh_cn&edition=full","pubTime":"2024-06-07 01:03","pubTimestamp":1717693384,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日01时03分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.03%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Virax Biolabs Group Limited、Fibrobiologics, Inc.、Replimune Group, Inc.涨幅较大，Virax Biolabs Group Limited、Geovax Labs, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为3035.57%、83.16%、39.03%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virax Biolabs Group Limited、Fibrobiologics, Inc.，振幅分别为129.76%、86.92%、70.00%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607010304aef3d5ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607010304aef3d5ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2441790172","title":"Processa Pharmaceuticals, Inc.盘中异动 快速拉升5.69%报1.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441790172","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441790172?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:42","pubTimestamp":1717594946,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日21时42分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.69%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Vir Biotechnology, Inc.、Eliem Therapeutics, Inc涨幅较大，Adial Pharmaceuticals, Inc、Cns Pharmaceuticals, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为43.93%、15.17%、5.99%，振幅较大的相关个股有Silo Pharma, Inc.、Cns Pharmaceuticals, Inc.、Maia Biotechnology, Inc.，振幅分别为23.56%、20.79%、19.57%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605214226af8c287f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605214226af8c287f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2441258620","title":"Processa Pharmaceuticals, Inc.盘中异动 快速上涨5.62%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441258620","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441258620?lang=zh_cn&edition=full","pubTime":"2024-06-05 00:11","pubTimestamp":1717517465,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日00时11分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.62%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Annexon, Inc.、Cingulate Inc C/Wts 10/12/2026 、Olema Pharmaceuticals, Inc.涨幅较大，Bio-Path Holdings, Inc.、Silo Pharma, Inc.、Annexon, Inc.较为活跃，换手率分别为75.86%、45.82%、41.56%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Seastar Medical Holding Corp C/Wts 28/10/2027 、Annexon, Inc.，振幅分别为181.00%、60.77%、35.37%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605001105af8bf1c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605001105af8bf1c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2439145627","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.23%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439145627","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439145627?lang=zh_cn&edition=full","pubTime":"2024-05-31 00:31","pubTimestamp":1717086693,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日00时31分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.23%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531003134aef29447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531003134aef29447&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2438308381","title":"Processa Pharmaceuticals, Inc.盘中异动 快速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438308381","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438308381?lang=zh_cn&edition=full","pubTime":"2024-05-28 22:00","pubTimestamp":1716904846,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日22时00分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.19%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.71%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Exicure, Inc.、Mustang Bio, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为49.85%、14.09%、11.74%，振幅较大的相关个股有Exicure, Inc.、G1 Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为70.52%、21.76%、20.73%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528220047941eaa09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528220047941eaa09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.processapharmaceuticals.com","stockEarnings":[{"period":"1week","weight":-0.0575},{"period":"1month","weight":-0.1633},{"period":"3month","weight":0.025},{"period":"6month","weight":-0.2},{"period":"1year","weight":-0.784},{"period":"ytd","weight":-0.7549}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Processa Pharmaceuticals, Inc.成立于2011年3月29日。该公司是一家临床阶段的生物制药公司，致力于药物产品的开发，该产品旨在为高度未满足的患者提供治疗方法并改善其生存率和生活质量。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.245296},{"month":2,"riseRate":0.666667,"avgChangeRate":0.111339},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.094091},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.072959},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.095736},{"month":6,"riseRate":0.714286,"avgChangeRate":0.170494},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.138494},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.064365},{"month":9,"riseRate":0.666667,"avgChangeRate":0.119026},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.111719},{"month":11,"riseRate":0.333333,"avgChangeRate":0.108897},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.158361}],"exchange":"NASDAQ","name":"Processa Pharmaceuticals, Inc.","nameEN":"Processa Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Processa Pharmaceuticals, Inc.,PCSA,Processa Pharmaceuticals, Inc.股票,Processa Pharmaceuticals, Inc.股票老虎,Processa Pharmaceuticals, Inc.股票老虎国际,Processa Pharmaceuticals, Inc.行情,Processa Pharmaceuticals, Inc.股票行情,Processa Pharmaceuticals, Inc.股价,Processa Pharmaceuticals, Inc.股市,Processa Pharmaceuticals, Inc.股票价格,Processa Pharmaceuticals, Inc.股票交易,Processa Pharmaceuticals, Inc.股票购买,Processa Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}